Tandem mass spectrometric analysis of cyclophosphamide, ifosfamide and their metabolites

Rapid Communications in Mass Spectrometry

Volumn 19, Issue 18, 2005, Pages 2581-2590

  Liu, Zhongfa ^a   Chan, Kenneth K ^a,c   Wang, Jeffrey J ^b,d  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; ETHYLENE; MASS SPECTROMETERS; MASS SPECTROMETRY; POSITIVE IONS;

ANALYTES; ELECTROSPRAY MASS SPECTROMETRY; FRAGMENTATION PATHWAYS; IFOSFAMIDE; ION ELECTROSPRAY; ION TRAP MASS SPECTROMETER; MULTI-STAGES; TANDEM MASS SPECTRA; TANDEM MASS SPECTROMETRIC ANALYSIS; TOF MASS SPECTROMETER;

METABOLITES;

EID: 25144494249     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/rcm.2099     Document Type: Article

References (17)

1. Brock N. Oxazaphosphorine cytostatics: In Structure-Activity Relationships of Anti-tumor Agents, Reinhoudt DN, Connors TA, Pinedo HM, van de Poll KW (eds). Martinus Nijhoff: The Hague, 1983; 239.
2. Hill DL. A Review of Cyclophosphamide. Thomas CC: Springfield, Illonis, 1975.
3. Zon G. In Progress in Medicinal Chemistry, vol. 19, Eliis GP, West GB (eds). Elsevier Biochemical Press: Amsterdam, 1982; 205.
4. Friedman OM, Myles A, Colvin M. Advances in Cancer Chemotherapy. A. Marcel Dekker Inc.: New York. 1979; 143.
5. Stec WJ. J. Organophosphorus Chem. 1982; 13: 145.
6. Busker E, Koberstein E, Niemeyer U, Engel J, Linscheid M. J. Biomed. Mass Spectrom. 1987; 163.
7. Castiglia L, Miraglia N, Pieri M, Genovese G, Simonelli A, Basilicata P, Sannolo N, Acampora A. Rapid. Commun. Mass Spectrom. 2005; 19: 1858.
8. Wang JH, Chan KK. J. Labelled Compd. Radiopharm. 1996; 38: 105.
9. Colvin M, Padgett CA, Fenselau C. Cancer Res. 1973; 4: 915.
10. Connors TA, Cox PJ, Farmer PB, Foster AB, Jarman M. Biochem. Pharmacol. 1974; 23: 115.
11. Allen LM, Creaven PJ. Cancer Chemother. Rep. Part 1 1972; 56: 603.
12. Struck RF, Kirk MC, Mellett LB, Dareer S, Hill DL. Mol. Pharmacol. 1971; 7: 519.
13. Struck RF, Kirk MC, Witt MH, Laster WR. J. Biomed. Mass Spectrom. 1975; 2: 46.
14. Hong PS, Srigritsanapol A, Chan KK. Drug Metab. Disp. 1991; 19: 1.
15. Chan KK, Hong PS, Kendra K, Trump DL. Cancer Res. 1994; 54: 6421.
16. Tew K, Colvin MO, Chabner BA. In Cancer Chemotherapy and Biotherapy, Chabner BA, Longo DL (eds). Lippincott-Raven: Philadephia, 1996; 297-332.
17. Boyd VL, Summers MF, Ludeman SM, Egan W, Zon G, Regan JB. J. Med. Chem. 1987; 30: 366.